KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Clinical trial NCT02646839 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT02646839
Sponsor: Michael Pulsipher
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2015-10-01
Primary completion: 2025-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.